Asia-Pacific Leads Liquid Biopsy Market Expansion with Rising Cancer Rates and Improving Diagnostics Infrastructure
The Asia-Pacific region is rapidly emerging as a growth engine for the global liquid biopsy market, driven by a confluence of factors: rising cancer incidence, increasing healthcare spending, and advancements in diagnostics infrastructure. While North America and Europe have traditionally dominated oncology diagnostics, APAC’s unique challenges—including limited access to tissue...
0 Commentarii 0 Distribuiri 7 Views 0 previzualizare
Lifesone https://lifesone.com